MENU
+Compare
BRSYF
Stock ticker: OTC
AS OF
Aug 12 closing price
Price
$5.49
Change
+$2.09 (+61.47%)
Capitalization
292.74M

BRSYF Brainsway Ltd. Forecast, Technical & Fundamental Analysis

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders... Show more

BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BRSYF with price predictions
Sep 04, 2025

BRSYF's Stochastic Oscillator sits in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for BRSYF turned negative on September 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BRSYF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.046) is normal, around the industry mean (59.958). P/E Ratio (39.214) is within average values for comparable stocks, (37.886). BRSYF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.671). BRSYF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (4.690) is also within normal values, averaging (80.383).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
19 Hartum Street
Phone
+972 25824030
Employees
106
Web
https://www.brainsway.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DQICX33.860.33
+0.98%
BNY Mellon Equity Income Fund C
NQCAX5.590.05
+0.90%
Nuveen Large Cap Value Opportunities A
TIGRX16.310.14
+0.87%
Nuveen Core Equity R6
HFEAX57.240.41
+0.72%
Janus Henderson European Focus A
SCIUX11.860.07
+0.59%
Invesco Income Advantage U.S. Fund R5

BRSYF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BRSYF has been loosely correlated with ANSLY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if BRSYF jumps, then ANSLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRSYF
1D Price
Change %
BRSYF100%
N/A
ANSLY - BRSYF
61%
Loosely correlated
+1.44%
KSRBF - BRSYF
51%
Loosely correlated
N/A
VERO - BRSYF
28%
Poorly correlated
+4.11%
WUXIF - BRSYF
27%
Poorly correlated
N/A
FSPKF - BRSYF
25%
Poorly correlated
N/A
More

Groups containing BRSYF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRSYF
1D Price
Change %
BRSYF100%
N/A
Health Services
category (438 stocks)
5%
Poorly correlated
+0.20%
Medical/Nursing Services
category (226 stocks)
5%
Poorly correlated
+0.21%